These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 12464360

  • 1. Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist.
    De Vry J, Rüdiger Jentzsch K.
    Eur J Pharmacol; 2002 Dec 20; 457(2-3):147-52. PubMed ID: 12464360
    [Abstract] [Full Text] [Related]

  • 2. Discriminative stimulus effects of the structurally novel cannabinoid CB1/CB2 receptor partial agonist BAY 59-3074 in the rat.
    De Vry J, Jentzsch KR.
    Eur J Pharmacol; 2004 Nov 28; 505(1-3):127-33. PubMed ID: 15556145
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties.
    Mauler F, Mittendorf J, Horváth E, De Vry J.
    J Pharmacol Exp Ther; 2002 Jul 28; 302(1):359-68. PubMed ID: 12065738
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discriminative stimulus properties of the 5-HT1A receptor agonist BAY x 3702 in the rat.
    De Vry J, Jentzsch KR.
    Eur J Pharmacol; 1998 Sep 11; 357(1):1-8. PubMed ID: 9788767
    [Abstract] [Full Text] [Related]

  • 7. (R)-Methanandamide and delta9-tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A.
    Järbe TU, Lamb RJ, Liu Q, Makriyannis A.
    Eur J Pharmacol; 2003 Apr 11; 466(1-2):121-7. PubMed ID: 12679148
    [Abstract] [Full Text] [Related]

  • 8. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.
    Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R.
    Eur J Pharmacol; 2003 Feb 07; 461(1):27-34. PubMed ID: 12568912
    [Abstract] [Full Text] [Related]

  • 9. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.
    Norwood CS, Cornish JL, Mallet PE, McGregor IS.
    Eur J Pharmacol; 2003 Mar 28; 465(1-2):105-14. PubMed ID: 12650839
    [Abstract] [Full Text] [Related]

  • 10. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    Izzo AA, Mascolo N, Pinto L, Capasso R, Capasso F.
    Eur J Pharmacol; 1999 Nov 12; 384(1):37-42. PubMed ID: 10611417
    [Abstract] [Full Text] [Related]

  • 11. Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo.
    Acquas E, Pisanu A, Marrocu P, Di Chiara G.
    Eur J Pharmacol; 2000 Aug 04; 401(2):179-85. PubMed ID: 10924924
    [Abstract] [Full Text] [Related]

  • 12. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.
    Järbe TU, Liu Q, Makriyannis A.
    Psychopharmacology (Berl); 2006 Jan 04; 184(1):36-45. PubMed ID: 16307294
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells.
    Ihenetu K, Molleman A, Parsons M, Whelan C.
    Eur J Pharmacol; 2003 Mar 19; 464(2-3):207-15. PubMed ID: 12620515
    [Abstract] [Full Text] [Related]

  • 14. 3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074): a novel cannabinoid Cb1/Cb2 receptor partial agonist with antihyperalgesic and antiallodynic effects.
    De Vry J, Denzer D, Reissmueller E, Eijckenboom M, Heil M, Meier H, Mauler F.
    J Pharmacol Exp Ther; 2004 Aug 19; 310(2):620-32. PubMed ID: 15140913
    [Abstract] [Full Text] [Related]

  • 15. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ, Crim JL, Darmani NA.
    Pharmacol Biochem Behav; 2002 Aug 19; 71(1-2):155-62. PubMed ID: 11812518
    [Abstract] [Full Text] [Related]

  • 16. Effects of pharmacological manipulations of cannabinoid receptors on severity of dystonia in a genetic model of paroxysmal dyskinesia.
    Richter A, Löscher W.
    Eur J Pharmacol; 2002 Nov 15; 454(2-3):145-51. PubMed ID: 12421641
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
    Hough LB, Nalwalk JW, Stadel R, Timmerman H, Leurs R, Paria BC, Wang X, Dey SK.
    J Pharmacol Exp Ther; 2002 Oct 15; 303(1):314-22. PubMed ID: 12235266
    [Abstract] [Full Text] [Related]

  • 18. Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats.
    Fattore L, Spano MS, Cossu G, Deiana S, Fratta W.
    Eur J Neurosci; 2003 Apr 15; 17(8):1723-6. PubMed ID: 12752390
    [Abstract] [Full Text] [Related]

  • 19. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia.
    Rawls SM, Cabassa J, Geller EB, Adler MW.
    J Pharmacol Exp Ther; 2002 Jun 15; 301(3):963-8. PubMed ID: 12023525
    [Abstract] [Full Text] [Related]

  • 20. Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands.
    Smith SR, Terminelli C, Denhardt G.
    Eur J Pharmacol; 2001 Aug 03; 425(1):73-83. PubMed ID: 11672577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.